Skip to main content

SAFE vs Convertible Note: A Founder's Guide to Choosing the Right Early-Stage Financing

· 11 min read
Mike Thrift
Mike Thrift
Marketing Manager

Picture this: you've got six months of runway, a working prototype, and an angel investor ready to wire $250,000 tomorrow morning. The only question left is what paper to sign. Choose the wrong instrument and you could give away an extra 8% of your company, trigger a default in 18 months, or hand future investors a reason to walk away from your priced round.

For pre-seed and seed-stage startups, the choice almost always comes down to two instruments: a Simple Agreement for Future Equity (SAFE) or a convertible note. Both let you raise money without setting a valuation today. Both convert into equity when you eventually close a priced round. But underneath that surface, they behave very differently — and the difference can quietly shape your cap table, your runway, and your relationship with investors.

2026-05-03-safe-vs-convertible-note-startup-financing-founder-guide

This guide walks through how each instrument works, what the key economic terms actually mean for your equity, and how to decide which one fits your round.

The Core Difference: Equity Promise vs Debt

A SAFE is a contract — not a loan. The investor wires money in exchange for the right to receive shares in your company at a later date, when you raise a priced round (usually a Series A or seed round with a defined valuation). There's no interest. No maturity date. No obligation to repay if the priced round never happens.

A convertible note is a loan. The investor lends your company money, the company promises to pay it back with interest, and there's a maturity date by which the loan must either be repaid or converted into equity. Most of the time, the note converts during your next priced round — but if that round doesn't happen before maturity, the note becomes due.

This single distinction — contract vs debt — drives nearly every other difference between the two instruments.

How Conversion Actually Works

Both instruments convert into equity at your next priced round. The mechanics are nearly identical, governed by two key terms: the valuation cap and the discount rate.

Valuation Cap

The valuation cap is the maximum company valuation at which your investor's money will convert into shares, no matter how high the actual round valuation ends up.

Suppose an angel invests $200,000 on a SAFE with a $5 million post-money valuation cap. Two years later, you close a Series A at a $20 million pre-money valuation. The angel's $200,000 doesn't convert at $20 million — it converts as if the company were valued at $5 million. That's a 4x better price per share than what new investors are paying, rewarding the angel for taking early risk.

For most pre-seed rounds today, valuation caps land between $6 million and $15 million. Seed rounds often see caps between $10 million and $25 million depending on traction.

Discount Rate

The discount rate gives the investor a percentage off the priced round's per-share price. A 20% discount means the investor pays 80 cents for every share new investors are paying $1 for.

Most convertible notes include both a cap and a discount, with the investor receiving whichever produces the better per-share price at conversion. SAFEs commonly use just a cap, though some include a discount as well.

Worked Example

A founder raises $500,000 on a SAFE with a $10 million post-money valuation cap. The Series A closes at $25 million pre-money, with new investors buying shares at $2.50 each.

  • New investors pay $2.50 per share.
  • The SAFE investor's effective price is $1.00 per share (because the SAFE caps valuation at $10M when the actual is $25M).
  • The $500,000 SAFE converts into 500,000 shares — about 5% of the post-conversion company.
  • Without the cap, that $500,000 at $2.50 per share would have purchased only 200,000 shares (about 2%).

The cap protected the investor from being diluted by the company's growth between the SAFE and the priced round.

The Mechanics That Make Notes and SAFEs Diverge

Interest and Maturity (Convertible Notes Only)

Convertible notes typically carry an annual interest rate of 4–8%. That interest accrues during the note's life and gets added to the principal at conversion, increasing the number of shares the investor receives.

Maturity dates usually sit 18 to 24 months out. If a priced round closes before maturity, the note converts cleanly. If it doesn't, the note technically becomes due — meaning the investor can demand repayment, force conversion at a low default valuation, or renegotiate. In practice, most investors agree to extend the maturity date because suing a struggling startup rarely produces cash. But the leverage shifts decisively to the investor at that moment.

A common founder mistake: setting a 12-month maturity when the realistic timeline to a Series A is 18 months. That cliff creates avoidable stress and can hand investors negotiating leverage you didn't intend to give up.

Liquidation Priority

If the company is acquired or shut down before conversion, convertible noteholders are creditors. They get paid before SAFE holders and before common stockholders. SAFE holders typically sit ahead of common but behind any actual debt. In a wind-down scenario, this priority matters.

Pro-Rata Rights

Pro-rata rights let an investor maintain their ownership percentage by participating in future financing rounds. Both instruments can include pro-rata rights, though Y Combinator's standard post-money SAFE separates these into a side letter rather than baking them into the SAFE itself. Be deliberate about which investors get pro-rata — promising them broadly can crowd out future lead investors.

Most Favored Nation (MFN) Provisions

An MFN clause says: "If you give a future investor better terms than mine, I get those terms too." Common in SAFEs issued at the very earliest stage when the company isn't ready to commit to a cap. The risk for founders is that MFN provisions can cascade — a single low cap given to one later investor automatically resets terms for every prior MFN holder.

The Pre-Money vs Post-Money SAFE Distinction

In 2018, Y Combinator replaced the original SAFE with a post-money SAFE, and the difference matters a lot.

Under the original (pre-money) SAFE, the investor's ownership percentage was diluted by every subsequent SAFE you issued. If you raised a series of SAFEs, no individual investor knew exactly how much of the company they'd own until the priced round closed.

Under the post-money SAFE, ownership is calculated as Investment ÷ Post-Money Cap, locked in at signing. A $375,000 SAFE at a $15 million post-money cap converts to exactly 2.5% of the company — period. Future SAFEs don't dilute the existing SAFE holders.

This is mathematically clean for investors but quietly punishing for founders. Every additional post-money SAFE dilutes only the founders and the option pool, not prior SAFE holders. Stack three or four post-money SAFEs without paying close attention and you can give away 25% or more of the company before you realize what's happened.

If you're issuing post-money SAFEs, run the dilution math after each one. Don't just track the dollars raised.

When to Use a SAFE

A SAFE makes sense when:

  • You're at pre-seed or very early seed stage with no revenue or just initial traction.
  • You want to close fast. SAFEs typically run 5–6 pages, with no negotiation over interest rates or maturity dates.
  • You don't want a debt obligation on your balance sheet. Convertible notes appear as liabilities; SAFEs do not.
  • You're raising from sophisticated investors (angels, accelerators, micro-VCs) who understand the instrument.
  • You expect to raise a priced round within a reasonable timeframe — 18 to 36 months is a comfortable window.

The downside: SAFEs are an evolving area of law in some jurisdictions, and outside the US (and outside ecosystems familiar with YC's templates) some investors will push back.

When to Use a Convertible Note

A convertible note is often the better fit when:

  • You're raising from less startup-native investors (friends, family, regional angels) who view a debt instrument as more familiar and protective.
  • You want to give investors creditor-level downside protection in exchange for a tighter cap or other concessions.
  • You're outside the US in a jurisdiction where SAFE templates aren't well established.
  • Your investors specifically want interest as part of their return.
  • You're raising a bridge round between priced rounds — convertible notes are often used here because the eventual conversion event (the next equity round) is well-defined.

The trade-off: more terms to negotiate, more complexity at conversion, and a real risk if the maturity date arrives before the priced round.

Common Pitfalls Founders Make

Stacking SAFEs without tracking cumulative dilution. Each SAFE feels small in isolation. Cumulatively, four SAFEs at varying caps can carve out a quarter of your equity before you've sold a single share of preferred stock.

Setting unrealistic maturity dates on convertible notes. A 12-month maturity is almost never long enough. Default to 24 months or longer for any seed-stage note.

Issuing MFN SAFEs early, then giving better terms later. That cheaper cap you gave a later investor just propagated backward through every MFN holder.

Promising pro-rata rights to too many investors. When your Series A lead wants to take 30% of the round, you may discover that 25% is already locked up by SAFE holders' pro-rata rights.

Confusing pre-money and post-money SAFEs. They look nearly identical on paper. The dilution implications are not. Read the title of the document carefully and run the math both ways before signing.

Failing to record the SAFE or note in your books. Even though SAFEs aren't debt, they represent a real future claim on equity and should be tracked rigorously alongside your cap table from day one.

Tracking Convertibles in Your Financial Records

Convertible notes appear on your balance sheet as liabilities — typically classified as long-term debt — with accrued interest tracked as an expense each period. SAFEs are trickier. Under US GAAP, most SAFEs end up classified as equity or as a liability measured at fair value, depending on the specific terms. The accounting treatment matters when investors review your financials, when you file taxes, and especially when you eventually convert these instruments at a priced round.

Maintaining clean records of every SAFE and note — principal amount, valuation cap, discount rate, MFN status, pro-rata commitments, conversion date — is essential. When your Series A lead's lawyers begin diligence, they will reconstruct the post-conversion cap table down to the share. Discrepancies between what you remember signing and what your records show can delay a closing by weeks.

A Simple Decision Framework

Ask yourself these questions in order:

  1. Are you raising from US-based startup-native investors? If yes, SAFE is usually the default. If no, lean toward a convertible note.
  2. Do you have a clear path to a priced round within 24 months? If yes, either works. If you're uncertain, SAFE removes the maturity-date risk.
  3. Will you raise multiple convertible instruments before the priced round? If yes, model the dilution carefully. Post-money SAFEs especially require disciplined tracking.
  4. Is this a bridge between equity rounds? Convertible notes with a defined maturity often fit better here because the conversion event is well-scoped.
  5. What does your investor want? Sophisticated angels usually default to SAFEs. Less startup-experienced investors often prefer the perceived safety of a note.

Keep Your Cap Table Clean from Day One

Whether you choose a SAFE or a convertible note, the financial impact compounds with every subsequent raise. Tracking each instrument's terms, accrued interest, conversion mechanics, and dilution effects across multiple rounds gets complicated quickly — and getting it wrong before your Series A diligence can cost you weeks at exactly the wrong moment.

Beancount.io provides plain-text accounting that's transparent, version-controlled, and AI-ready — perfect for founders who need a clear, auditable record of every dollar that comes in and every share that gets promised. No black boxes, no vendor lock-in, just the kind of clean financial records your future Series A lead's lawyers will thank you for. Get started for free and keep your books clean from the very first SAFE.